News
1d
New Scientist on MSNHuman trials point the way towards an mRNA vaccine against HIVWe may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...
A breakthrough in our understanding of mRNA delivery systems in the body may allow for more direct treatments for ...
A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with JN.1-updated mRNA COVID-19 vaccines, reinforcing their safety profile and ...
The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.
StockStory.org on MSN18h
Moderna Earnings: What To Look For From MRNABiotechnology company Moderna (NASDAQ:MRNA) will be reporting results this Friday before the bell. Here’s what to expect.
An mRNA cancer vaccine triggered strong immune responses and improved treatment outcomes in mice, offering a new approach to ...
The company last reported total revenues of $108M in Q1, down 35.3% Y/Y due to lower net product sales, particularly its ...
3h
New Scientist on MSNAgeing in the brain may be caused by a breakdown in protein productionThe discovery that brain ageing may be driven by jammed-up protein factories could lead to better ways to help us stay sharp ...
Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult ...
Analysts have given Moderna a total of 6 ratings, with the consensus rating being Neutral. The average one-year price target ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results